Shell has over 19 years of cGXP global supply chain, operations, and logistics experience with no disruption to supply in cGXP pharma/biotech industry. He has an MBA and 2 Engineering degrees, plus Lean & Six Sigma skills (business, technical, & optimization skills). He has a deep understanding of clinical and commercial supply chain management, procurement, strategic sourcing, production planning and control, contract/external manufacturing, as well as global logistics (Import/Export), and business and supplier management.
He is regularly involved in professional presentations, panel/roundtable discussions, and publications.
Tieming holds his Ph.D. in Mechanical Engineering from the Ohio State University and MBA from New York University. He led different combination product developments such as Auto-Injector, Prefilled Syringe, Large volume wearable injector. He has been working for various biotech and medical device companies in the past eighteen years and holds 15+ patents of drug delivery devices.
Scott Sutton is the Sr. Director, Supply Chain for MorphoSys in Boston, MA. He has 20 years of experience managing both clinical and commercial supply chains across a wide variety of drugs and therapeutic areas, with an emphasis in oncology and rare disease. Scott’s supply chain experience ranges across Phase I to Phase IV clinical trials, commercial product launches, global supply management, vendor sourcing, international logistics, and sales & operations planning management.
Imran has 18 years of experience in the industry with the last 15 years focusing on IRT oversight from both the vendor and sponsor sides at companies that include ClinPhone, ICON, Takeda, Boehringer Ingelheim and currently Biogen. Imran is responsible for the clinical supply chain systems group where, in addition to IRT, he also oversees other supply chain capabilities like the demand planning and forecasting tool, temperature monitoring, and ERP systems. Imran’s passion in clinical research, however, is devoted to thinking about how our industry can leverage the power of technology to make clinical trials more efficient and enable the delivery of effective investigational products to patients and their advocates.
Dr Aneja is Head of Digital Strategy at Sanofi with board member roles at MIT, Oliver Wyman, MedCity News and acting as an Advisor to Harvard Innovation Labs. Rajni was formerly the Global Head of Digital Strategy for Novartis. She is a Connection Science Fellow with expertise in population health management and digital health. Rajni is an advisor to a variety of health and wellness organisations.
Moon H. Kim, PhD.
PhD: Medicinal Chemistry at SNU
MSKCC, SUNY Buffalo, Affymax, Exelixis in US
OncoVenture, IPK, ARIBIO, BiSiChem, VeraVerse in Korea
InnoCure Therapeutics, CTO
Michael is the Managing Director of NVC, a globally unique association where more than 500 companies cooperate for the benefit of both their own future and that of the activity of packaging in general. With great experience in guiding companies and employees to achieve individual and collective goals in this field.
